United States: Digital Health Innovation In The United States And United Kingdom: The Promise And Challenge Of Government Reimbursement Policies

Digital health has excited health care innovators for many years, but understanding how these tools can fit within existing health care financial structures is critical for success.


Unfortunately, neither the U.S. nor the UK public health systems have created a comprehensive framework to support digital health tools generally. There are a number of reasons for this.

First, public health systems charged with paying for products and services must evaluate their efficacy and costeffectiveness in order to responsibly provide reimbursement. While both the National Health Service (NHS) in the United Kingdom and the Department of Health and Human Services in the United States have made some progress, neither reimbursement system is set up to perform the difficult task of quickly and effectively evaluating the vast range of constantly evolving products and services within the digital health sector.

Second, many digital health tools do not fall within the scope of services traditionally offered by public health systems. Disease monitoring, wellness, and prescription or therapy adherence tools, for example, traditionally have not been reimbursed in the fee-for-service or provider tariff-based models in either country. Accordingly, these products would increase expenditures under government reimbursement programs, at least in the short term.

Third, even if a tool is effective at treating a condition, and is otherwise cost effective compared to alternatives, the tool may increase utilisation and, ultimately, financial cost.

Without a doubt, these are difficult challenges, but an uncertain reimbursement landscape has a number of negative consequences for maximising the potential for digital health solutions.

First, the hype around digital health could result in a digital health "bubble", where value is inflated and not reflected in future revenue streams.

Second, many digital health solutions may not presently be financially viable, leaving only digital giants able to afford the front-end carrying costs, and resulting in fewer suppliers further down the road.

Third, the types of digital health tools adopted by practitioners could be limited. Providers may want to invest only in digital health products that result in cost savings related to the delivery of health care services, and may lack incentives to invest in digital health products that aim to prevent or delay interventions through self-management or early intervention, if this reduces their volume of services.

This is not to say that health care providers are motivated solely by economics, and we roundly reject this sentiment. At the same time, however, it would be foolish not to acknowledge the fact that economic factors must come into play in decision making: providers must be able to financially sustain themselves.

Finally, if the health care provider community is not actively adopting these tools, then their patients may not have an incentive to do so themselves.


All is not doom and gloom, however. Payment systems in both the United Kingdom and United States have been evolving to support digital health innovation.

In the United States, for example, reimbursement for telemedicine services has slowly been gaining ground. Medicaid programmes reimburse a wide range of telemedicine services and Medicare, despite continuing to burden telemedicine reimbursement with highly restrictive qualification requirements, continues to add services subject to reimbursement. Most states have legislatively mandated that private insurance programs reimburse telemedicine services, and in some instances mandate reimbursement at the same economic level as in-person services.

More interesting and, in the longrun more importantly, the United States is slowly evolving into a "value-based" reimbursement market, where reimbursement for medical services is increasingly subject to quality and efficiency standards. In a recent survey, digital health companies indicated that this has been the most significant force for digital health adoption.

The vast number of value-based systems, and their complexity, can pose a challenge. Each value-based Federal or state payment programme has its own unique blend of quality and efficiency metrics and incentives.

While there is some commonality across programmes, proving a digital health tool's value for specific programmes requires some work. For example, the recently announced Bundled Payments for Care Improvement Advanced (BPCIA) provides a bundled payment to cover specific inpatient and outpatient episodes. Specific quality measures will be tracked and payments will be adjusted accordingly. Digital health tools can benefit providers looking to participate in BPCIA, but the most attractive will be those with use cases that can be applied to the specified episodes of care and help to achieve success under the specified quality metrics.

Similarly, since 2014, UK NHS policy has been to move to an integrated or accountable care model of health care providers, using outcomes or value based metrics and digital and data analytics to manage overall demand for care. A few areas have moved quickly to value-based contracts where the providers take overall budget responsibility for managing care. Unsurprisingly, these areas and primary care providers, where pricing is based on a price per patient, have been keen to adopt new technologies. Progress overall has, however, been somewhat "stop start" as fears of privatisation have recently slowed progress.

In theory, digital health tools are key levers to help NHS providers deliver care to a set budget. The real challenge is whether NHS commissioners have unrealistic expectations about the savings to be delivered from day one so that budgets do not give sufficient incentives to providers to move away from a tariff model or invest in new tools.

Other developments are more promising. In 2017, a new NHS "innovation" tariff was introduced for commissioners to purchase approved digital health tools. At the same time, the national tariff rules explicitly encouraged local commissioners and providers to reach pricing agreements where care was provided remotely.

So far, the only digital health tool covered by the innovation tariff is a mobile chronic obstructive pulmonary disease product, to be funded by commissioners at £20 per patient. On one level, this tariff is encouraging, because it formally recognises the role of digital technology. But, a payment directly to a digital health company by a commissioner (bypassing the health care provider) may not create the right long-term incentives for providers to manage overall cost or for digital health manufacturers to maximise value.


Government, by its nature, is slow to act and slow to change. So we must recognise that from a reimbursement prospective, it's still early days. When contrasted with the clear interest of consumers and providers, the gap between demand and reimbursement can seem vast.

It is important to bear in mind, however, that public payment programmes must balance a competing set of interests. Digital health innovators who see government reimbursement as a key to a promising future would be well-served to help the government address these issues, and in so doing, help to shape the future innovation of health care.

Digital Health Innovation In The United States And United Kingdom: The Promise And Challenge Of Government Reimbursement Policies

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Sign Up
Gain free access to lawyers expertise from more than 250 countries.
Email Address
Company Name
Confirm Password
Mondaq Newsalert
Select Topics
Select Regions
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions